Oral Sleep Apnea Devices Market Size - By Device Type (Mandibular Advancement Devices, Tongue-retaining Devices, Rapid Maxillary Expansion), By Indication, By Purchase Type, By Gender, By End-use, By Distribution Channel & Forecast, 2024 – 2032

Oral Sleep Apnea Devices Market Size

Oral Sleep Apnea Devices Market size was valued at USD 1.3 billion in 2023 and is expected to grow at a CAGR of 10.7% between 2024 and 2032, due to growing prevalence of sleep apnea and related co-morbidities, surging awareness regarding sleep apnea and other sleep disorders, and the rising demand for oral sleep apnea devices.
 

A major factor contributing to the growing demand for oral sleep apnea devices is the rising incidence of sleep apnea and related comorbidities. For instance, according to the National Council on Ageing, in 2023, approximately 936 million adults around the world were estimated to have mild to severe obstructive sleep apnea (OSA). As awareness about sleep apnea continues to grow among healthcare providers and the general population, more individuals are being diagnosed with the condition. Sleep studies and screenings are becoming more common, leading to higher rates of detection. With an increased emphasis on diagnosing sleep apnea and its associated risks, there is a corresponding rise in the demand for effective treatment options, including oral sleep apnea devices.
 

Oral sleep apnea devices are medical devices designed to treat obstructive sleep apnea and snoring by repositioning the lower jaw and tongue to maintain an open upper airway during sleep. These devices are custom-made or adjustable and are typically worn in the mouth during sleep to prevent the collapse of soft tissues in the throat that lead to airway obstruction.
 

Oral Sleep Apnea Devices Market Trends

Advancements in healthcare technology have played a pivotal role in shaping and improving various medical interventions, and this progress has significantly contributed to the growth and development of oral sleep apnea devices. These technological innovations have enhanced the effectiveness, comfort, and accessibility of oral appliances for oral sleep apnea devices, making them more efficient tools in the management of obstructive sleep apnea.
 

• Modern oral sleep apnea devices feature adjustable titration mechanisms that allow for fine-tuning of the device's position and advancement of the lower jaw. This adjustability enables healthcare providers to optimize treatment efficacy and address individual patient needs, ensuring optimal airflow and reducing the risk of side effects such as jaw discomfort or tooth movement. Adjustable titration mechanisms enhance the versatility and effectiveness of oral devices in managing sleep apnea.
   
• Moreover, advancements in 3D printing technology enable the precise customization of oral sleep apnea devices to fit the unique anatomical characteristics of each patient's mouth and jaw. Dental professionals can create personalized devices with optimal fit and comfort, improving patient compliance and treatment outcomes. 3D printing also allows for rapid prototyping and manufacturing, reducing production time and costs associated with traditional methods. Such advancements are gaining the attention of healthcare professionals and patients resulting in increasing demand in the market.
   

Oral Sleep Apnea Devices Market Analysis

The market by device type is categorized into mandibular advancement devices, tongue-retaining devices, rapid maxillary expansion, and mouth guards. The mandibular advancement devices segment held over USD 499.4 million revenue in 2023.
 

• Mandibular advancement devices (MADs) are clinically proven to effectively treat mild to moderate cases of obstructive sleep apnea by repositioning the lower jaw forward during sleep. This forward movement helps prevent airway collapse and obstruction, allowing for improved airflow and reduced apnea events. MADs offer a viable alternative to continuous positive airway pressure (CPAP) therapy, particularly for patients who find CPAP masks uncomfortable or intolerable.  
   
• Moreover, MADs are known for their comfort and ease of use compared to other oral sleep apnea devices. They are custom-fitted to each patient's mouth for optimal comfort and minimal interference with speech or swallowing. The non-invasive nature of MADs and their ability to integrate seamlessly into the patient's nightly routine promote better compliance and long-term adherence to treatment, leading to improved patient outcomes. Due to such advantages, the segment is set to grow over the forecast period.
   

The oral sleep apnea devices market by indication is categorized into mild sleep apnea, moderate sleep apnea, and severe sleep apnea. The mild sleep apnea segment recorded around USD 660.7 million revenue in 2023.
 

• Compared to CPAP therapy, which requires the purchase of a machine and ongoing maintenance, oral sleep apnea appliances are often more cost-effective for patients with mild sleep apnea. Oral sleep apnea appliances typically have a lower upfront cost and do not require regular replacement parts or filters, making them a more affordable treatment option for individuals with mild symptoms who may not have severe airflow obstruction.
   
• Additionally, many patients with mild sleep apnea prefer oral sleep apnea appliances over CPAP therapy due to factors such as comfort, ease of use, and convenience. Oral sleep apnea appliances are custom-fitted to each patient's mouth and jaw, ensuring a comfortable fit and minimal disruption to sleep. This increased patient satisfaction and compliance contribute to the dominance of the mild sleep apnea segment in the market.  
   

The oral sleep apnea devices market by purchase type is categorized into physician-prescribed/customized oral devices and OTC oral devices. The physician-prescribed/customized oral devices segment dominates the market with a revenue of USD 846.4 million in 2023.
 

• Physician-prescribed or customized oral sleep apnea implants are tailored to each patient's specific needs and oral anatomy. Healthcare providers, often working in collaboration with dental professionals, assess the patient's condition, conduct diagnostic evaluations, and recommend the most suitable device based on factors such as the severity of sleep apnea, anatomical considerations, and patient preferences. This personalized approach ensures optimal treatment outcomes and patient satisfaction.
   
• Furthermore, physician-prescribed oral devices are typically provided under the supervision of healthcare professionals, that monitor treatment progress, adjust device settings as needed, and provide ongoing support and guidance to patients. This professional oversight ensures that patients receive comprehensive care and have access to expert advice throughout the treatment process, leading to better treatment outcomes and patient satisfaction.  
   

Based on gender, the oral sleep apnea devices market is segmented into male and female. The male segment is anticipated to reach USD 2.4 billion by 2032.
 

• Studies have consistently shown that sleep apnea is more prevalent in males compared to females. Men are at a higher risk of developing sleep apnea due to factors such as increased body weight, larger neck circumference, and anatomical differences in upper airway structure. For instance, according to an article published by Mayo Clinic, in 2023, men are 2 to 3 times more likely to have sleep apnea than women. As a result, there is a larger pool of male patients seeking treatment for sleep apnea, driving the dominant market share in oral sleep apnea devices.
   
• Further, the anatomical differences between males and females, particularly in upper airway anatomy and craniofacial structure, may influence the efficacy of oral sleep apnea devices. Devices designed to advance the mandible and open the airway may be more effective in males due to differences in jaw size and configuration, contributing to their higher utilization and market share in this demographic, contributing to market growth positively.
   

The oral sleep apnea devices market by end-use is categorized into homecare settings, sleep laboratories & hospitals, and dental clinics. The homecare settings segment was valued at USD 789.2 million revenue in 2023.
 

• Homecare use of oral sleep apnea devices offers patients the convenience and comfort of managing their condition in the comfort of their own homes. Unlike traditional treatments like continuous positive airway pressure (CPAP) therapy, which requires cumbersome equipment and masks, oral devices are compact, portable, and easy to use, making them ideal for home-based treatment.
   
• Moreover, for individuals with mild to moderate sleep apnea or those who struggle with CPAP therapy, oral sleep apnea devices offer a non-invasive alternative that can effectively alleviate symptoms without the need for continuous monitoring or adjustment by healthcare professionals. This makes them well-suited for use in home settings, where patients can self-manage their treatment regimen, contributing to segmental growth.

The oral sleep apnea devices market by distribution channel is categorized into brick and mortar, e-commerce, and hospital pharmacies. The brick and mortar segment crossed USD 614.6 million revenue in 2023.
 

• Brick-and-mortar establishments offer access to comprehensive care services beyond just the provision of oral sleep apnea devices. Patients can receive ongoing monitoring, follow-up appointments, and support services to ensure the effectiveness of treatment and address any concerns or complications that may arise. This holistic approach to patient care fosters long-term patient-provider relationships and promotes continuity of care.
   
• Moreover, these establishments provide hands-on fitting and adjustment services for oral sleep apnea devices, ensuring proper customization and optimal fit for each patient. Dental professionals or sleep specialists can make necessary adjustments to the device to address comfort issues, maximize effectiveness, and promote patient adherence to therapy. This personalized approach enhances patient satisfaction and treatment outcomes.

North America oral sleep apnea devices market size exceeded USD 482 million in 2023.
 

• North America has a notably high prevalence of sleep apnea, with millions of individuals affected by this condition. Factors such as obesity, sedentary lifestyles, and aging populations contribute to the increasing prevalence of sleep apnea in the region. For instance, according to the American Medical Association, in 2022, about 30 million people in the U.S. have sleep apnea. The increasing incidence of such sleep disorder has propelled the demand for oral sleep apnea devices, making North America a dominant market for these essential medical appliances.
   
• North America is a hub for technological innovation and research in the field of sleep medicine. The region is home to leading medical device manufacturers, research institutions, and academic centers focused on developing advanced oral sleep apnea devices. Continuous advancements in device design, materials, and technology contribute to the effectiveness, comfort, and usability of oral devices, further driving their market growth.
   

Oral Sleep Apnea Devices Market Share

The oral sleep apnea devices industry is marked by fragmentation, with a multitude of both major multinational corporations and smaller to medium-sized enterprises vying for dominance and market penetration. The industry features a wide range of oral sleep apnea devices catering to different patient needs and preferences. The development and launch of these novel devices with improved efficiency and cost-effectiveness are among a key market strategy for oral sleep apnea device manufacturers.
 

Oral Sleep Apnea Devices Market Companies

Some of the eminent market participants operating in the oral sleep apnea devices industry include:

• Apnea Sciences
• DynaFlex
• Glidewell
• MPowrx Health & Wellness
• Myerson LLC
• OravanOSA
• Panthera Dental
• ProSomnus Sleep Technologies
• PureSleep
• ResMed
• SomnoMed
• Vivos Therapeutics, Inc.
   

Oral Sleep Apnea Devices Industry News

• In November 2023, Vivos Therapeutics announced that the U.S. health regulator has cleared its oral device for severe obstructive sleep apnea (OSA). The clearance is the first ever for an oral appliance, along with a mode of respiratory ventilation or exercise training program for the muscles around the face, mouth and tongue, to treat moderate and severe OSA in adults. This product approval may help the company to gain a competitive edge over its peers.
   
• In May 2023, Glidewell announced a new addition to its family of sleep solutions, the flexTAP mandibular advancement device (MAD). This product launch helped the company to expand its business revenue.
   

The oral sleep apnea devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Device Type

• Mandibular advancement devices
• Tongue-retaining devices
• Rapid maxillary expansion
• Mouth guards

Market, By Indication

• Mild sleep apnea
• Moderate sleep apnea
• Severe sleep apnea

Market, By Purchase Type

• Physician-prescribed/customized oral devices
• OTC oral devices

Market, By Gender

• Male
• Female

Market, By End-use

• Homecare settings
• Sleep laboratories & hospitals
• Dental clinics

Market, By Distribution Channel

• Brick and mortar
• E-commerce
• Hospital pharmacies

The above information has been provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa